tiprankstipranks
Trending News
More News >
Genmab (Otc) (GMAB)
NASDAQ:GMAB

Compare Genmab (GMAB) vs. Competitors

Compare
766 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Genmab
$33.27
$19.79B
13.74
69.14%
5 Buy
2 Hold
0 Sell
Moderate Buy
BioMarin Pharmaceutical
$57.95
$10.86B
21.71
-8.54%
8 Buy
5 Hold
0 Sell
Moderate Buy
Incyte
$102.67
$19.65B
17.22
38.44%
7 Buy
8 Hold
1 Sell
Moderate Buy
Ascendis Pharma
$223.59
$13.81B
-52.65
71.12%
13 Buy
0 Hold
0 Sell
Strong Buy
BioNTech SE
$108.88
$27.35B
-12.03%
12 Buy
2 Hold
0 Sell
Strong Buy
Royalty Pharma
$42.36
$24.06B
23.83
34.14%
3 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
GMAB
Genmab
33.27
14.06
73.19%
BMRN
BioMarin Pharmaceutical
57.95
-4.92
-7.83%
INCY
Incyte
102.67
28.55
38.52%
ASND
Ascendis Pharma
223.59
101.34
82.90%
BNTX
BioNTech SE
108.88
-8.26
-7.05%
RPRX
Royalty Pharma
42.36
11.87
38.93%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts